CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has announced an amendment to its restricted share award scheme, which from 21 May 2024 will be funded solely by existing shares purchased on-market, reflecting the scheme’s operation since its inception in 2018. This change ensures that no new shares will be issued to satisfy share awards, thereby aligning the interests of selected participants with those of the shareholders without affecting any accrued rights.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
